Nafamostat mesylate sensitizes ovarian cancer cells to carboplatin by promoting the ZNF24-mediated inhibition of WNT2B
Released on J-STAGE: November 01, 2024 |
Volume 49
Issue 11
Pages 467-479
Jiehuan Xu, Jianlin Chen, Dao Wang, Yaojun Li, Ping Lian, Xiaozhu Wu, Rong Yan